Home » Topics » BioWorld Science

BioWorld Science
RSS

ALT-711 may be effective in improving cardiovascular remodeling in hypertension

Sep. 28, 2001

Enrollment completed for phase I/II StreptAvax trial

Sep. 28, 2001

Inhibitors of cytokine production under development by Hokuriku Seiyaku

Sep. 27, 2001

Phosphonic acid-based inhibitors of FBPase synthesized at Metabasis

Sep. 27, 2001

Recent U.S. patent covers new sulfonamides and use for atherosclerosis, restenosis

Sep. 27, 2001

HIV reverse transcriptase inhibitors described by Pfizer team

Sep. 27, 2001

Genaera receives Cystic Fibrosis Foundation grant to develop Lomucin

Sep. 27, 2001

Lundbeck presents several classes of 5-HT1A receptor ligands

Sep. 27, 2001

Inflazyme initiates two trials to study novel antiinflammatory compounds

Sep. 27, 2001

InterMune acquires worldwide rights to oritavancin from Lilly

Sep. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...